- World rank, 2022–2025
- #22,817 of 28,054 · #31,391 all time
- Rank in Ireland
- #65 of 79
- Research works
- 160 ▲ 107% vs 2013–17
- Citations
- 1.7k 10.3 per fractional work
- Top-10% rate
- 9.4% record average 16.5%
- Open access
- 51% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Economics, Econometrics and Finance, 5.4×. Every wedge is a field page.
- Economics, Econometrics and Finance 5.4×
- Immunology and Microbiology 3.6×
- Medicine 3.4×
- Pharmacology, Toxicology and Pharmaceutics 1.6×
- Health Professions 1.5×
- Decision Sciences 1.0×
- Veterinary 0.9×
- Mathematics 0.8×
- Biochemistry, Genetics and Molecular Biology 0.6×
- Neuroscience 0.6×
- Chemistry 0.5×
- Agricultural and Biological Sciences 0.3×
- Psychology 0.2×
- Engineering 0.2×
- Social Sciences 0.1×
- Environmental Science 0.1×
- Computer Science 0.1×
- Arts and Humanities 0.1×
- Materials Science 0.0×
Which keywords describe research at Novartis (Ireland)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Quality of Life, Autoantibodies, Cost-effectiveness Analysis, Health Utility Measures, Diagnosis, Epidemiology, Inflammation and Clinical Trials.
- Breast Cancer
- Drug Development Costs
- Pharmaceutical Industry
- Cognitive Impairment
- Statins
- Lymphoma
- Prognostic Factors
- Cytokines
- Biomarkers
- Refractive Error
- Visual Impairment
- Diagnostic Criteria
- Chronic Spontaneous Urticaria
- Rituximab
- BCR-ABL
- Autoimmune
- Clinical Trials
- Inflammation
- Cost-effectiveness Analysis
- Epidemiology
- Quality of Life
- Autoantibodies
- Health Utility Measures
- Diagnosis
- Treatment
- Management
- Imatinib
- Immunosuppressive Therapy
- Urticaria
- Global Prevalence
- Myopia
- Thrombosis
- Cardiovascular Disease Prevention
- Genetic Variants
- Health Outcomes
- Intravenous Immunoglobulin
- Cholesterol-lowering
- LDL Cholesterol
- Chronic Disease Management
- Generic Drugs
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Quality of Life10▲ 9.6×12 topics
- Epidemiology8▲ 2.6×28 topics
- Autoantibodies6▲ 34×5 topics
- Cost-effectiveness Analysis6▲ 92×1 topic
- Health Utility Measures6▲ 92×1 topic
- Inflammation5▲ 3.7×18 topics
- Diagnosis5▲ 7.4×9 topics
- Clinical Trials4▲ 7.7×10 topics
- Treatment4▲ 4.3×13 topics
- Autoimmune4▲ 103×2 topics
- Management3▲ 5.9×7 topics
- BCR-ABL3▲ 162×1 topic
- Imatinib3▲ 162×1 topic
- Rituximab3▲ 29×4 topics
- Immunosuppressive Therapy3▲ 23×5 topics
- Chronic Spontaneous Urticaria2▲ 151×1 topic
- Urticaria2▲ 151×1 topic
- Diagnostic Criteria2▲ 15×4 topics
- Global Prevalence2▲ 35×2 topics
- Visual Impairment2▲ 67×2 topics
- Myopia2▲ 53×1 topic
- Refractive Error2▲ 82×1 topic
- Thrombosis2▲ 11×5 topics
- Biomarkers2▲ 4.0×6 topics
- Cardiovascular Disease Prevention2▲ 32×2 topics
- Cytokines2▲ 9.3×3 topics
- Genetic Variants2▲ 15×3 topics
- Prognostic Factors2▲ 5.8×6 topics
- Health Outcomes2▲ 8.8×4 topics
- Lymphoma2▲ 15×3 topics
- Intravenous Immunoglobulin2▲ 34×3 topics
- Statins2▲ 29×2 topics
- Cholesterol-lowering1▲ 43×1 topic
- Cognitive Impairment1▲ 7.5×3 topics
- LDL Cholesterol1▲ 57×1 topic
- Pharmaceutical Industry1▲ 50×2 topics
- Chronic Disease Management1▲ 9.4×5 topics
- Drug Development Costs1▲ 68×1 topic
- Generic Drugs1▲ 68×1 topic
- Breast Cancer1▲ 7.3×5 topics
Which research topics does Novartis (Ireland) publish most on?
By volume in 2022–2025: Health Systems, Economic Evaluations, Quality of Life, Chronic Myeloid Leukemia Treatments, Urticaria and Related Conditions and Ophthalmology and Visual Impairment Studies.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 6 works
- 2 Chronic Myeloid Leukemia Treatments Hematology 3 works
- 3 Urticaria and Related Conditions Rheumatology 2 works
- 4 Ophthalmology and Visual Impairment Studies Epidemiology 2 works
- 5 Lipoproteins and Cardiovascular Health Surgery 1 works
- 6 Pharmaceutical Economics and Policy Economics and Econometrics 1 works
- 7 Coagulation, Bradykinin, Polyphosphates, and Angioedema Genetics 1 works
- 8 Multiple Sclerosis Research Studies Pathology and Forensic Medicine 1 works
- 9 Autoimmune Bullous Skin Diseases Pathology and Forensic Medicine 1 works
- 10 Biomedical and Engineering Education Biomedical Engineering 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Novartis (Ireland)'s research output changed?
Output in 2018–2022 was 107% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Cork
- University College Cork
- Cork University Hospital
- Munster Technological University
- Infant
- APC Microbiome Institute
- Mercy University Hospital
- United Technologies Research Center
- National Cancer Registry
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.